Abstract: A method for collecting peripheral blood mononuclear cells following mobilizing chemotherapy in pediatric patients is described. The critical elements of the method included temporary heparinization of the patient to reduce citrate overload, and limiting extracorporeal circulation to 15% of the patient's blood volume using packed red blood cells and albumin. A median of 0.9x10(8) mononuclear cells/kg per collection were harvested in 40 collections from eight patients with only one episode of fever and chills. Peripheral blood stem cells were reinfused into six of these patients with refractory/recurrent pediatric tumors after intensive chemotherapy. Bone marrow reconstitution followed with a mean of 30 days (19-38) for absolute ne...
Purpose—This prospective study was designed to determine the safety and efficacy of cyclophosphamide...
By 2003, 97% autologous transplants and 65% of allogeneic transplants in Europe used m...
This prospective study was designed to determine the safety and efficacy of cyclophosphamide, BCNU, ...
AbstractThirty-five pediatric patients, 1-16 years of age (median 6.3 years), with neoplastic solid ...
Background : Peripheral blood stem cell (PBSC) transplantation has been widely used to support the h...
Abstract Simultaneous comparative assessment of tumor contamination in bone marrow aspirates and pe...
Today, hematopoietic stem cell transplantation (HSCT) is a standard treatment for a variety of condi...
Peripheral blood stem cells (PBSCs) are the preferred source in autologous transplantation. We asses...
Cumulative myelosuppression is the main limiting factor for administration of repeated cycles of che...
Stem cells capable of restoring hematopoiesis following lethal bone marrow injury circulate in the b...
Forty-seven peripheral blood stem cell (PBSC) collections were carried out on patients mobilized wit...
UNIFESP, Pediat Oncol Inst, GRAACC, Sao Paulo, BrazilUNIFESP, Pediat Oncol Inst, GRAACC, Sao Paulo, ...
Autologous transplant of lymphocyte-depleted peripheral blood stem cells has been proposed for treat...
The additive effect of peripheral blood stem cells (PBSCs) to autologous bone man ow transplantation...
The mobilization of stem cells from bone marrow to peripheral blood in can-cer patients administered...
Purpose—This prospective study was designed to determine the safety and efficacy of cyclophosphamide...
By 2003, 97% autologous transplants and 65% of allogeneic transplants in Europe used m...
This prospective study was designed to determine the safety and efficacy of cyclophosphamide, BCNU, ...
AbstractThirty-five pediatric patients, 1-16 years of age (median 6.3 years), with neoplastic solid ...
Background : Peripheral blood stem cell (PBSC) transplantation has been widely used to support the h...
Abstract Simultaneous comparative assessment of tumor contamination in bone marrow aspirates and pe...
Today, hematopoietic stem cell transplantation (HSCT) is a standard treatment for a variety of condi...
Peripheral blood stem cells (PBSCs) are the preferred source in autologous transplantation. We asses...
Cumulative myelosuppression is the main limiting factor for administration of repeated cycles of che...
Stem cells capable of restoring hematopoiesis following lethal bone marrow injury circulate in the b...
Forty-seven peripheral blood stem cell (PBSC) collections were carried out on patients mobilized wit...
UNIFESP, Pediat Oncol Inst, GRAACC, Sao Paulo, BrazilUNIFESP, Pediat Oncol Inst, GRAACC, Sao Paulo, ...
Autologous transplant of lymphocyte-depleted peripheral blood stem cells has been proposed for treat...
The additive effect of peripheral blood stem cells (PBSCs) to autologous bone man ow transplantation...
The mobilization of stem cells from bone marrow to peripheral blood in can-cer patients administered...
Purpose—This prospective study was designed to determine the safety and efficacy of cyclophosphamide...
By 2003, 97% autologous transplants and 65% of allogeneic transplants in Europe used m...
This prospective study was designed to determine the safety and efficacy of cyclophosphamide, BCNU, ...